Kevin Schwartzman Selected Research

Kevin Schwartzman Research Topics

22	Tuberculosis (Tuberculoses) 01/2022 - 12/2004
12	Latent Tuberculosis 01/2021 - 08/2004
10	Infections 01/2022 - 12/2004
2	Hepatitis 11/2021 - 11/2008
2	Neoplasms (Cancer) 01/2020 - 01/2019
2	Asthma (Bronchial Asthma) 07/2012 - 08/2002
1	Diabetes Mellitus 11/2021
1	Renal Insufficiency (Renal Failure) 11/2021
1	Rectal Neoplasms (Rectal Cancer) 01/2020
1	Silicosis 11/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Systemic Scleroderma (Systemic Sclerosis) 06/2018
1	Interstitial Lung Diseases (Interstitial Lung Disease) 06/2018
1	Latent Infection 01/2018
1	Coinfection 05/2015
1	Substance-Related Disorders (Drug Abuse) 05/2015
1	Hepatitis C 05/2015
1	Blindness (Hysterical Blindness) 02/2014
1	Reinfection 12/2004
1	Chemical and Drug Induced Liver Injury 08/2004
1	Hyperparathyroidism 10/2002
1	Osteoporosis 10/2002
1	Chronic Obstructive Pulmonary Disease (COPD) 08/2002

15	Isoniazid (Ftivazide)FDA LinkGeneric 01/2022 - 08/2004
10	Rifampin (Rifampicin)FDA LinkGeneric 11/2021 - 08/2004
5	Tuberculin (PPD)IBA 01/2012 - 09/2005
3	Interferon-gamma (Interferon, gamma)IBA 06/2013 - 01/2012
2	rifapentine (Priftin)FDA Link 01/2021 - 01/2018
2	VaccinesIBA 01/2014 - 01/2011
1	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 01/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 11/2021
1	cyclo(Arg-Pro) (CI 4)IBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2019
1	Biomarkers (Surrogate Marker)IBA 06/2018
1	Ethambutol (Myambutol)FDA LinkGeneric 02/2014
1	Tuberculosis VaccinesIBA 01/2014
1	Indicators and Reagents (Reagents)IBA 11/2006
1	DNA (Deoxyribonucleic Acid)IBA 06/2005
1	Rifabutin (Ansamycin)FDA Link 12/2004
1	CalciumIBA 10/2002
1	MineralsIBA 10/2002

7	Therapeutics 01/2020 - 08/2004
2	Aftercare (After-Treatment) 05/2015 - 12/2004
1	Treatment Delay 01/2020
1	Drug Therapy (Chemotherapy) 01/2019
1	Preoperative Exercise 01/2019
1	Time-to-Treatment 01/2016
1	Long-Term Care 09/2013
1	Patient Readmission 07/2012
1	Chemoprevention 09/2011
1	Contraindications 11/2008
1	Medical Day Care (Partial Hospitalization) 08/2002
1	Emergency Treatment 08/2002
1	Nebulizers and Vaporizers (Inhaler) 08/2002